Executive VP of R&D, Operations, and Service Departs
OM sits 63% above its 52-week low of $3.
Summary
Outset Medical announced the departure of Marc Nash, its Executive Vice President of R&D, Operations, and Service, effective June 5, 2026, to pursue other professional opportunities.
Key Events · Executive and Board Changes · OM
-
Executive Departure
Marc Nash, Executive Vice President of R&D, Operations, and Service, will depart the company on June 5, 2026.
-
Reason for Departure
Mr. Nash is leaving to pursue other professional opportunities, and his departure is not due to any dispute or disagreement with the company.
Analysis · OM · Industrial Applications And Services
Marc Nash, Executive Vice President overseeing critical functions like R&D, Operations, and Service, is departing Outset Medical. While the company states his departure is amicable and for other opportunities, the loss of a senior executive in these key areas can create uncertainty regarding leadership continuity and strategic direction, especially for a company of this size.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, OM was trading at $4.89 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $90.5M. The 52-week trading range was $3.00 to $21.98. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.